Elevating Patient Care: Senderra Specialty Pharmacy Adds Lilly's EBGLYSS™ (lebrikizumab-lbkz) to SenderraCare+

SenderraCare+ redefines specialty therapy by consolidating enrollment, adherence support, and medication management into one intuitive, in real-time digital platform. It accelerates treatment initiation, enhances patient compliance, drastically cuts abandonment, and empowers patients and providers with actionable insights for seamless, high-quality care.

DALLAS, TX, August 8, 2025 - Senderra Specialty Pharmacy announced today the addition of EBGLYSS, Lilly’s first-line biologic treatment for moderate-to-severe atopic dermatitis in adults and pediatric patients 12 years of age or older who weigh at least 40 kg, who are not well controlled with prescription topical therapies, or who cannot use topical therapies to SenderraCare+. This innovative digital solution provides patients with a seamless, interactive patient journey in real-time, including status updates regarding their medication and two-way communication throughout the process. It is conveniently delivered to the patient's mobile phone, tablet, or desktop. Lilly joins top pharmaceutical manufacturers that have engaged with Senderra to provide this turn-key digital service for patients on specialty medications. This innovative solution solves several key issues impeding patient healthcare related to specialty medications. 

“We’re thrilled to integrate EBGLYSS into our innovative SenderraCare+ platform, setting a new standard for patient-focused specialty care,” said Will Howard, CEO and Co-Founder of Senderra Specialty Pharmacy. “At Senderra, we constantly pursue innovations that improve the specialty medication experience, working alongside Lilly and our network of providers to find opportunities, solve challenges, and deliver seamless, top-tier experiences for every patient.”

Key benefits of SenderraCare+ are the ability to reduce the onboarding time for patients to start their medications, improvements in medication adherence, and a reduction in patient abandonment. Patients may enroll through a digital SMS text as soon as they leave their provider's office and preschedule a welcome call with a member of Senderra’s patient care team to begin their therapy. The digital solution empowers patients to take control of their journey, providing the ability to digitally sign the consent, provide personal demographic information, upload insurance information, schedule a welcome call and a delivery time of their choice for the prescribed medications as well as the ability to schedule medication refills and request a live, patient consultation from a pharmacist or nurse. All of these features are hosted in a safe and secure environment, allowing the patient process flow to accelerate seamlessly due to digital contact, two-way interaction, and patient engagement.

The health care providers’ offices also benefit from SenderraCare+, as Senderra provides prior authorization services for all patient prescriptions. This high-touch level of service frees up time in the providers’ offices. Senderra’s service model ensures each prescription receives prior authorization before filling or, if necessary, is transferred to a mandated specialty pharmacy. Additionally, Senderra established a SenderraCare+ Provider Network, which automatically enrolls the patient in SenderraCare+ as soon as the prescription is sent to Senderra, providing a streamlined process for the patient to begin therapy faster. Senderra currently supports over 12,000 providers across the country and keeps providers informed about the patient's journey throughout the process. 

About Senderra Specialty Pharmacy 

Senderra is the largest national independent full-service specialty pharmacy serving patients with challenging and ongoing medical conditions by providing specialty medications, clinical expertise, and extensive patient support services. Senderra’s commitment to patient care is strengthened by its commitment to innovative technology solutions to improve healthcare experiences, specialized patient care teams, and strong relationships with our prescribers, pharmaceutical manufacturers, and payer partners. For more information on Senderra Specialty Pharmacy, please visit http://www.senderrarx.com.

About senderra

Senderra is a national specialty pharmacy, serving patients with challenging and ongoing medical conditions through provision of specialty medications, clinical expertise and support services. 

We dedicate ourselves to designing and executing a model to serve the needs of our patients and partners (Prescribers, Pharma and Payers) in order to make a difference and effect positive outcomes.